Article

Genomic Investigation for Potential Therapeutic Use of Abiraterone in the Amazonian Indigenous Population

2024-05-01

Abstract excerpt

Prostate cancer, according to the World Health Organization (WHO), ranks as the fourth most prevalent type in the population, even though it is highly frequent when detected early and promptly treated, resulting in a low mortality rate. However, in some cases, despite adherence to proper clinical protocols, there is a progression to castration-resistant prostate cancer (CRPC). In these cases, as outlined in clinic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 733545e0-24ae-5aa0-9e79-90af8915d6bd
DOI: 10.20944/preprints202405.0043.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genomic Investigation for Potential Therapeutic Use of Abiraterone in the Amazonian Indigenous PopulationDOI 10.20944/preprints202405.0043.v1Read

Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer.Semantic proximity Read

Androgen receptor variation affects prostate cancer progression and drug resistance.Semantic proximity Read

Androgen receptor: past, present and future.Semantic proximity Read

A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancerSemantic proximity Read

Androgen resistance--the clinical and molecular spectrum.Semantic proximity Read

Benign prostatic hyperplasia genetic variants in Asians.Semantic proximity Read

HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studiesSemantic proximity Read

A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate CancerSemantic proximity Read

The association between missense polymorphisms in SRD5A2 and HSD3B1 and treatment failure with abiraterone for castration-resistant prostate cancer.Semantic proximity Read

Association of Missense Polymorphism inHSD3B1With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or AbirateroneSemantic proximity Read

Allelic variability in PSA & AR genes: a novel biomarker on the horizon for carcinoma prostate.Semantic proximity Read

Evolution of the Primate Androgen Receptor: A Structural Basis for DiseaseSemantic proximity Read